Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intrum in connection with several financing transactions (1)
Mandate

Vinge advises Intrum in connection with several financing transactions

September 20, 2019 Banking and Finance

Vinge has advised Intrum AB (publ) in connection with several financing transactions during the third quarter of 2019.

Intrum issued notes in the amount of 750 MEUR in July  and 850 MEUR in September and entered into a 2,000 MSEK backup credit facility agreement with Nordic banks in July 2019. Vinge has advised Intrum as to matters of Swedish law in relation to all transactions. 

Vinge’s team consisted of amongst others Louise Brorsson Salomon, Josefine Larsson, Pauline Lagerstrand, Jolinn Uhlin and Anders Sundin Lundberg.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025